JB
Joel Beatty Baird Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Editas Medicine
EDIT
$251M
| $2.79 | $6 |
115%
upside
| Outperform |
13 Aug ‘25
26 days ago |
|
2
Cogent Biosciences
COGT
$1.77B
| $12.68 | $9 |
29%
downside
| Neutral |
8 Jul ‘25
2 months ago |
|
3
e.l.f. Beauty
ELF
$7.83B
| $138 | $145 |
5%
upside
| Outperform |
6 Jun ‘25
3 months ago |
|
4
Acadia Pharmaceuticals
ACAD
$4.28B
| $25.39 | $31 |
22%
upside
| Outperform |
19 May ‘25
3 months ago |
|
5
Neurogene
NGNE
$278M
| $19.45 | $24 |
23%
upside
| Neutral |
16 May ‘25
3 months ago |
|
6
Dianthus Therapeutics
DNTH
$1.02B
| $31.80 | $50 |
57%
upside
| Outperform |
13 May ‘25
3 months ago |
|
7
argenx
ARGX
$47B
| $768 | $680 |
11%
downside
| Outperform |
13 May ‘25
3 months ago |
|
8
Denali Therapeutics
DNLI
$2.27B
| $15.50 | $29 |
87%
upside
| Outperform |
8 May ‘25
4 months ago |
|
9
PTC Therapeutics
PTCT
$4.52B
| $56.95 | $66 |
16%
upside
| Outperform |
7 May ‘25
4 months ago |
|
10
Jazz Pharmaceuticals
JAZZ
$7.88B
| $129.85 | $155 |
19%
upside
| Outperform |
7 May ‘25
4 months ago |
|
11
Axsome Therapeutics
AXSM
$6.45B
| $129.29 | $162 |
25%
upside
| Outperform |
6 May ‘25
4 months ago |
|
12
Alkermes
ALKS
$4.7B
| $28.45 | $41 |
44%
upside
| Outperform |
2 May ‘25
4 months ago |
|
13
Larimar Therapeutics
LRMR
$336M
| $3.93 | $10 |
154%
upside
| Outperform |
25 Mar ‘25
5 months ago |
|
14
MindMed
MNMD
$714M
| $9.39 | $16 |
70%
upside
| Outperform |
7 Mar ‘25
6 months ago |
|
|
CTNM
15
Contineum Therapeutics
CTNM
$340M
| $12.13 | $16 |
32%
upside
| Outperform |
7 Mar ‘25
6 months ago |
|
16
Praxis Precision Medicines
PRAX
$858M
| $40.75 | $73 |
79%
upside
| Outperform |
3 Mar ‘25
6 months ago |
|
17
Catalyst Pharmaceutical
CPRX
$2.46B
| $20.08 | $32 |
59%
upside
| Outperform |
3 Mar ‘25
6 months ago |
|
|
DRUG
18
Bright Minds Biosciences
DRUG
$305M
| $42.97 | $75 |
75%
upside
| Outperform |
25 Nov ‘24
9 months ago |
|
19
Amylyx Pharmaceuticals
AMLX
$931M
| $10.44 | $11 |
5%
upside
| Outperform |
18 Nov ‘24
9 months ago |
|
|
IMMP
20
Immutep
IMMP
$252M
| $1.72 | $7 |
307%
upside
| Outperform |
15 Nov ‘24
9 months ago |
|
21
BioMarin Pharmaceuticals
BMRN
$10.8B
| $56.38 | $65 |
15%
upside
| Neutral |
30 Oct ‘24
10 months ago |
|
22
Ultragenyx Pharmaceutical
RARE
$3.04B
| $31.51 | $72 |
129%
upside
| Outperform |
31 May ‘24
1 year ago |
|
23
Calidi Biotherapeutics
CLDI
$8.83M
| $1.65 | $240 |
14,445%
upside
| Outperform |
15 May ‘24
1 year ago |
|
24
Geron
GERN
$874M
| $1.37 | $4.50 |
228%
upside
| Neutral |
30 Apr ‘24
1 year ago |
|
25
Nurix Therapeutics
NRIX
$742M
| $9.70 | $25 |
158%
upside
| Outperform |
11 Apr ‘24
1 year ago |
|